Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
The British Journal of Surgery
|
June 29, 2006
Redefining the R1 resection in pancreatic cancer
C S Verbeke, D Leitch, K V Menon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2008
An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer
F Caponigro, D Lacombe, C Twelves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Weekly 5-fluorouracil and leucovorin: achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resection
K Patel, D A Anthoney, A M Crellin, et al.
The British Journal of Surgery
|
December 31, 2013
Impact of intrapancreatic or extrapancreatic bile duct involvement on survival following pancreatoduodenectomy for common bile duct cancer
K Kamposioras, A Anthoney, C Fernández Moro, et al.
British Journal of Cancer
|
August 17, 2000
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)
J S de Bono, J Paul, A Simpson, et al.
British Journal of Cancer
|
April 20, 2006
A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma
M E Burge, D Smith, C Topham, et al.
Annals of Surgical Oncology
|
October 4, 2007
A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study
H Z Malik, S Farid, A Al-Mukthar, et al.
British Journal of Cancer
|
February 5, 2004
Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours
D A Anthoney, M J McKean, J T Roberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2010
Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study
M Ranson, M Reck, A Anthoney, et al.
Oncogene
|
July 3, 1997
hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents
R Brown, G L Hirst, W M Gallagher, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
The British Journal of Surgery
|
June 29, 2006
Redefining the R1 resection in pancreatic cancer
C S Verbeke, D Leitch, K V Menon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2008
An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer
F Caponigro, D Lacombe, C Twelves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Weekly 5-fluorouracil and leucovorin: achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resection
K Patel, D A Anthoney, A M Crellin, et al.
The British Journal of Surgery
|
December 31, 2013
Impact of intrapancreatic or extrapancreatic bile duct involvement on survival following pancreatoduodenectomy for common bile duct cancer
K Kamposioras, A Anthoney, C Fernández Moro, et al.
British Journal of Cancer
|
August 17, 2000
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)
J S de Bono, J Paul, A Simpson, et al.
British Journal of Cancer
|
April 20, 2006
A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma
M E Burge, D Smith, C Topham, et al.
Annals of Surgical Oncology
|
October 4, 2007
A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study
H Z Malik, S Farid, A Al-Mukthar, et al.
British Journal of Cancer
|
February 5, 2004
Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours
D A Anthoney, M J McKean, J T Roberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2010
Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study
M Ranson, M Reck, A Anthoney, et al.
Oncogene
|
July 3, 1997
hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents
R Brown, G L Hirst, W M Gallagher, et al.
Page
of 4